As of Feb 18, 2025, HCA Healthcare, Inc. Intrinsic Value is $369.3. This suggests it may be undervalued by 16.7% compared to its current price of around $316.5.
As of Feb 18, 2025, HCA Healthcare, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $261.3. This suggests it may be overvalued by 17.4% to its current price of around $316.5, using a discount rate of 10.6% and terminal growth rate of 3.0%.
HCA Healthcare, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $369.3, compared to a market price of around $316.5. This suggests a potential undervaluation of 16.7%.